BCL2L13 Rekombinanter Antikörper
BCL2L13 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250705F1
Kat-Nr. : 86183-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86183-1-PBS bindet in WB, Indirect ELISA BCL2L13 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | BCL2L13 fusion protein Ag9841 |
| Vollständiger Name | BCL2-like 13 (apoptosis facilitator) |
| Berechnetes Molekulargewicht | 485 aa, 53 kDa |
| Beobachtetes Molekulargewicht | 85 kDa |
| GenBank-Zugangsnummer | BC003032 |
| Gene symbol | BCL2L13 |
| Gene ID (NCBI) | 23786 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BCL2L13/MIL1 gene encodes a mitochondrially-localized protein with conserved B-cell lymphoma 2 homology motifs. BLC2L13 gene is highest expressed in heart, placenta and pancreas. The encoded protein Bcl-rambo may promote the activation of caspase-3 and apoptosis. The Bcl-rambo cell death activity was induced by its membrane-anchored C-terminal domain and not by the Bcl-2 homology region (PMID: 11262395). Multivariate analysis demonstrated that high expression of BCL2L13 was an independent prognostic factor for in childhood acute lymphoblastic leukemia (PMID: 20109966).



